Vinorelbine Tartrate — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

4 Recruiting

4 Completed trials

12 Sponsors

17 Countries

Phase II

Phase I/II

Phase III: 1 Phase II/III: 1 Phase II: 4 Phase I/II: 3 Phase IV: 1 Phase I (Other): 1

Oversight events:

1 serious breach 1 temporary halt 1 urgent safety measure across 1 trial

View oversight register →

Indications tested

Non-small cell lung cancer 2 Brain stem glioma 1 Rhabdomyosarcoma 1 Non-small cell lung cancer stage III 1 Malignant glioma 1

Sponsors using this IMP

Bristol Myers Squibb International Corporation 1 Centre Hospitalier Regional De Marseille 1 Centre Regional Lutte Contre Le Cancer 1 Delcath Systems Inc. 1 Fondazione IRCCS Istituto Nazionale Dei Tumori 1 Fondazione Italiana Linfomi Ets 1 I.F.O. Istituti Fisioterapici Ospitalieri 1 Institut Gustave Roussy 1 Intergroupe Francophone De Cancerologie Thoracique 1 Razor Genomics Inc. 1 Swiss Group for Clinical Cancer Research 1 The University Of Birmingham 1

All trials

11 total

A randomized, double-blinded, placebo-controlled, multicenter, phase II/III efficacy and safety study of oral TherO2-01S22 as add-on therapy… Pending

2024-516576-15-00 Phase II/III 1 country Centre Regional Lutte Contre Le Cancer
VINORELBINE INHIBITS ONCOGENIC FUNCTIONS OF MKK3: A NEW THERAPEUTIC OPPORTUNITY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER Pending

2024-519459-27-00 Phase II 1 country I.F.O. Istituti Fisioterapici Ospitalieri
Randomized Study to Evaluate Melphalan/HDS Treatment Followed by Treatment with Eribulin or Vinorelbine or Capecitabine Versus Eribulin or V… Recruiting

2025-521966-91-00 Phase II 4 countries Delcath Systems Inc.
phase I/II b study of atezolizumab and BEGEV as first salvage treatment in patients with relapsed or refractory Hodgkin’s lymphoma candidate… Recruiting

2024-511631-10-00 Phase I/II 1 country Fondazione Italiana Linfomi Ets
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Phase I/II 16 countries The University Of Birmingham
AcSé-ESMART: European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors Recruiting

2024-514791-40-00 Phase I/II 5 countries Institut Gustave Roussy
Radiotherapy to enhance the effects of an immune therapy before tumor surgery in patients with advanced non-small cell lung cancer (NSCLC). … Ended

2023-504536-18-00 Phase II 1 country Swiss Group for Clinical Cancer Research
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients with Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung… Ended

2024-511185-37-00 Phase IV 2 countries Intergroupe Francophone De Cancerologie Thoracique; Razor Genomics Inc.
Phase 2 open label randomized study of radiotherapy, concomitant nimotuzumab and vinorelbine and re-irradiation at relapse versus radiothera… Ended

2024-513654-30-00 Phase II 1 country Fondazione IRCCS Istituto Nazionale Dei Tumori
Phase 1 study of a Propranolol (HEMANGIOL®) and oral metronomic Vinorelbine (NAVELBINE®) combination on children and teenagers With Refracto… Halted

2024-517185-42-00 Phase I (Other) 1 country Centre Hospitalier Regional De Marseille
A Neoadjuvant Study of Nivolumab plus Ipilimumab or Nivolumab plus Chemotherapy versus Chemotherapy alone in Early Stage Non-Small Cell Lung… Ended

2022-501360-18-00 Phase III 4 countries Bristol-Myers Squibb International Corporation

Showing 1–11 of 11 trials

← All drugs A–Z